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Abstract
Background: The mechanisms by which malaria up and down-regulates CYP activities are not understood yet. It is
also unclear whether CYP activities are modulated during non-lethal malaria infections. This study was undertaken
to evaluate the time course of CYP alterations in lethal (Plasmodium berghei ANKA) and non-lethal (Plasmodium
chabaudi chabaudi) murine malaria. Additionally, hypotheses on the association of CYP depression with enhanced
nitric oxide (NO) production, and of CYP2a5 induction with endoplasmic reticulum dysfunction, enhanced haem
metabolism and oxidative stress were examined as well.
Methods: Female DBA-2 and C57BL/6 mice were infected with P.berghei ANKA or P. chabaudi and killed at
different post-infection days. Infection was monitored by parasitaemia rates and clinical signs. NO levels were
measured in the serum. Activities of CYP1a (ethoxyresorufin-O-deethylase), 2b (benzyloxyresorufin-O-debenzylase),
2a5 (coumarin-7-hydroxylase) and uridine-diphosphoglucuronyl-transferase (UGT) were determined in liver
microsomes. Glutathione-S-transferase (GST) activity and concentrations of gluthatione (GSH) and thiobarbituric
acid-reactive substances (TBARS) were determined in the liver. Levels of glucose-regulated protein 78 (GRP78) were
evaluated by immunoblotting, while mRNAs of haemoxygenase-1 (HO-1) and inducible nitric oxide synthase (iNOS)
were determined by quantitative RT-PCR.
Results: Plasmodium berghei depressed CYP1a and 2b and induced 2a5 in DBA-2 mice. In P.berghei-infected C57BL/
6 mice CYP activities remained unaltered. In both strains, GST and UGT were not affected by P.berghei. Plasmodium
c. chabaudi depressed CYP1a and 2b and induced 2a5 activities on the day of peak parasitaemia or near this day.
CYP2a5 induction was associated with over-expression of HO-1 and enhanced oxidative stress, but it was not
associated with GRP78 induction, a marker of endoplasmic reticulum stress. Plasmodium chabaudi increased serum
NO on days near the parasitaemia peak in both strains. Although not elevating serum NO, P.berghei enhanced
iNOS mRNA expression in the liver.
Conclusion: Down-regulation of CYP1a and 2b and induction of 2a5 occurred in lethal and non-lethal infections
when parasitaemia rates were high. A contribution of NO for depression of CYP2b cannot be ruled out. Results
were consistent with the view that CYP2a5 and HO-1 are concurrently up-regulated and suggested that CYP2a5
induction may occur in the absence of enhanced endoplasmic reticulum stress.
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Several studies have shown that stimulation of host
defense mechanisms against infections, as well as treat-
ment with pro-inflammatory cytokines, modulate the
expression and activity of cytochrome P450 enzymes
(CYP), thereby modifying the kinetics of drugs and toxi-
cants [1,2]. Along this line, it was reported that Plasmo-
dium berghei infection depressed the total content of
cytochrome P450s (CYPs) and the expression and activ-
ity of several CYP isoforms in the rodent liver [3-6].
Furthermore, it was recently shown that P.berghei
ANKA malaria induced CYP2a5 activity [7]. Since the
aforementioned studies evaluated CYP changes only at a
nearly terminal stage of lethal malaria, it remains
unclear whether up- and down-modulation of CYPs
occur at earlier stages of lethal infections and in non-
lethal infections as well.
The mechanism by which murine CYP2a5 and its
human orthologous 2A6 are up- or down-modulated by
infections and inflammatory stimuli remains largely
obscure. Kirby and coworkers suggested that inducers of
CYP2a5 have in common the property of causing oxida-
tive injury to endoplasmic reticulum (ER), thereby pro-
ducing an overexpression of GRP78 in hepatocytes [8,9].
Abu-Bakar et al [10], on the other side, suggested that
CYP2a5 and 2A6 play a major role in the oxidative
metabolism of bilirubin (BR), a breakdown product of
haem. Since induction of HO-1 results in elevated levels
of bilirubin, Abu-Bakar [10] advanced a hypothesis that
a concurrent up-regulation of haem-oxygenase (HO)
and CYP2a5 is critical for maintaining a balance
between production and elimination of BR. In human
Plasmodium falciparum and in rodent Plasmodium ber-
ghei malaria, intense haemolysis occurs and high levels
of circulating haem may be present [11-13]. In human
as well as in rodent cells, free haem excess up-regulates
the expression of HO-1, the rate limiting enzyme in the
process of converting potentially toxic free haem into
equimolar amounts of carbon monoxide (CO), biliverdin
and iron (Fe) [14,15].
It has been noted that nitric oxide (NO) causes a con-
centration-dependent inhibition of CYP activities in liver
microsomes in vitro [16,17]. Based on these findings, and
also on in vivo experiments in which iNOS inhibitors
partially reversed LPS-induced decline of liver CYP activ-
ities, Khatsenko et al [16] advanced a hypothesis that NO
overproduction mediates the decrease in CYP activities
induced by immunostimulation. Nonetheless, the idea
that NO mediates a general depression of CYP activities
caused by inflammatory and infectious stimuli remains
controversial. Sewer et al [18] reported that the down-
modulation of murine CYP2c29, 2e1 and 3a11 by the
Escherichia coli endotoxin in vivo occurs independently
of NO production, a conclusion that is at variance with
Khatsenko and coworkers’ hypothesis. The same authors,
however, observed a NO-dependent degradation of
CYP2b proteins, a finding that reveals a possible mechan-
istic link between NO overproduction and inhibition of
CYP2b during immunostimulation. In all aforementioned
studies host defense responses were stimulated either by
LPS or bacterial infections. So far no study has investi-
gated whether depression of CYP1a and 2b activities cor-
relates with periods of enhanced production of NO
during the course of parasitic infections.
This study was undertaken to provide data on the
time course of alterations of CYP2a5, 1a and 2b activ-
ities in the mouse liver during the evolution of lethal
(P.berghei ANKA) and non-lethal (Plasmodium cha-
baudi chabaudi) malaria infections. Along this line, it
was also examined whether down- modulation of CYP1a
and 2b activities correlates with periods of NO overpro-
duction during lethal and non-lethal infections. Addi-
tionally, the present study investigated whether the
induction of CYP2a5 activity was associated with ER
dysfunction (GRP78 protein overexpression), enhanced
haem metabolism (HO-1 induction) and oxidative stress.
The activity of uridine diphosphoglucuronyl transferase
(UGT), an enzyme that plays a critical role in the elimi-
nation of bilirubin, was evaluated in P.berghei-infected
mice as well [19].
Methods
Animals
F e m a l eD B A - 2a n dC 5 7 B L / 6m i c e ,7t o1 0w e e k so l d ,
from the Oswaldo Cruz Foundation (FIOCRUZ) breed-
ing stock were used. All mice were housed in standard
plastic cages with stainless steel covers and white wood
shavings as bedding. Temperature (23 ± 2°C), air relative
humidity (approximately 70%) and photoperiod (lights
on from 8:00 a.m. to 8:00 p.m.) were controlled in the
animals’ room. A commercial pellet diet (Nuvital CR1,
Nuvilab®, Curitiba, PR, Brazil) and filtered tap water
were provided ad libitum. The study protocol was
approved by the Ethics Committee on the Use of Ani-
mals of the Oswaldo Cruz Foundation (CEUA-
FIOCRUZ).
Chemicals
Substrates benzyloxy- and ethoxy-resorufin, coumarin,
p-nitrophenol, 1-chloro-2,4-dinitrobenzene, uridine
diphospho glucuronic acid (UDPGA), GSH, thiobarbitu-
ric acid (TBA), butylated hydroxytoluene (BHT), dithio-
threitol (DTT), EDTA, pyrazole, Bradford reagent, BSA,
sulphanylamide, naphtylenediamine dichlorhydrate
(NEED), nitrate reductase, sodium nitrate, b-NADPH,
b-NADP, glucose-6-phosphate, glucose-6-phosphate
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Page 2 of 17dehydrogenase, and E.coli LPS (type 0127:B8) were from
Sigma Chemical Co (St. Louis, MO, USA). All other
chemicals used in the experiments were of high analyti-
cal grade.
Parasites and infection
Parasites causing lethal (P.berghei ANKA strain) and non-
lethal (P.chabaudi chabaudi AS strain) malaria infections
in DBA-2 and C57BL/6 mice were used. Malaria-infected
animals were inoculated by the i.p. route with 0.2 mL of
PBS-diluted blood from a donor mouse containing either
10
6 (P.berghei)o r2×1 0
7 (P.chabaudi) parasitized ery-
throcytes (PE) per milliliter. The donor mice had been
inoculated with a stabilate of the parasite kept at -80°C in
Alsever’s solution. For each malaria-infected mouse, an
age-paired non-infected control animal of the same sex
and strain was injected with 0.2 mL of PBS solution.
After infection, mice were daily examined for clinical
signs of illness and a small drop of blood was taken from
the tail tip for determination of parasitaemia rates. The
percentage of parasitized erythrocytes (% PE) was deter-
mined by examining thin blood smears stained by the
Romanowski’s method (Panótico Rápido, Laborclin®, Pin-
hais, PR, Brazil). Groups of infected mice and their
matched non-infected controls were killed by cervical dis-
location at different times after infection. After death,
spleens and livers were removed as quickly as possible,
freed from fat and extra tissue, weighed, frozen and kept
at -80°C until further use.
Preparation of subcellular fractions for phase I and II
enzyme assays
Microsomal fraction I
Liver microsomal fraction I (MF I) was prepared as
described previously [20], except for the use of 100 mM
Tris 150 mM KCl buffer solution pH 7.4 instead of the
sucrose solution. Aliquots of MF I were stored at -80°C
until further use. MF I was used for the monooxygenase
and UGT activities.
Microsomal fraction II
Liver microsomal fraction II (MF II) was used for deter-
mination of microsomal glutathione S-transferase
(mGST) activity. It was prepared essentially as described
for MF I, except for using 150 mM Tris pH 8.0 buffer
solution to avoid cytosolic contamination [21]. Aliquots
of MF II were stored at -80°C until further use.
Cytosolic fraction
Liver cytosolic fraction (CF) was prepared as recom-
mended by Abel et al [ 2 2 ] .B r i e f l y ,l i v e rw a sh o m o g e -
neized in 10 mM Tris 250 mM sucrose 0.2 mM DTT
1 mM EDTA buffer solution pH 7.4 and centrifuged at
10 000 × g for 10 min at 4°C. The supernatant was then
centrifuged at 15 000 × g for 20 min at 4°C, filtered in
gauze and centrifuged at 105 000 × g for 1 h at 4°C.
Aliquots of CF were stored at -80°C until further assay
of the cytosolic GST (cGST) activity.
Total protein determination
Protein concentration in MF I, MF II and in CF was
determined using Bradford reagent and BSA as the stan-
dard [23]. The method was adapted to a microplate and
absorbance was read at 595 nm in a spectrophotometer
Spectramax Plus® (Molecular Devices, USA).
Enzyme assays
Monooxygenase reactions
Benzyloxy-(BROD) and ethoxy- (EROD) resorufin-O-
dealkylases were determined in 96-well microplates as
described by Kennedy and Jones [24], with some modifi-
cations [7]. Substrate final concentration was 5 μMa n d
0.025 mg of microsomal protein was added to each well
(MF I). After a 10-min incubation period at 37°C, 100 μL
of acetonitrile was added to each well and the amount of
resorufin was measured in a fluorescence plate reader
(Spectramax Gemini XS®, Molecular Devices, USA) with
excitation and emission wavelengths set at 530 and 590
nm, respectively.
Coumarin hydroxylase (COH) activity
COH activity was assayed as reported by Iersel et al [25]
with a few adaptations. 50 mM Tris buffer pH 7.4,
10 μM coumarin and 0.4 mg (DBA-2) or 0.8 mg
(C57BL/6) of protein was added to reaction tubes for a
final volume of 0.5 mL. After a 3 min pre-incubation
period, reaction was initiated by addition of a NADPH
regenerating system (0.5 mM b-NADP, 10 mM glucose
6-phosphate, 0.5 U/mL glucose 6-phosphate dehydro-
genase and 10 mM magnesium chloride). The reaction
took place for 10 min at 37°C with shaking and was
stopped by addition of HCl 2N. The reaction product
(umbelliferone or 7-hydroxycoumarin) was extracted
with chloroform and taken to tubes containing 1.6 M
glycine-NaOH solution pH 10.4. The amount of umbel-
liferone was measured by using a spectrofluorimeter
Shimadzu RF5301 PC® with excitation and emission
wavelengths set at 355 nm and 460 nm, respectively,
and a 3 nm band slit width.
Conjugation reactions
UGT activity
UGT activity was determined as reported by Bock et al
[26]. 100 mM Tris pH 7.4, 0.25% triton X-100, 5 mM
p-nitrophenol, 50 mM MgCl2 and 0.1 mg of protein
(MF I) were added to reaction tubes to a final volume
of 0.5 mL. After a 2 min pre-incubation period, UDPGA
(3 mM) was added to start the reaction. After 30 min,
trichloroacetic acid 5% was added to stop the reaction
and the samples were centrifuged at 2 300 rpm in a
bench centrifuge. 1 mL of supernatant was added to a
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were carried to a spectrophotometer Shimadzu UV
1601® set at 405 nm and the enzyme activity was calcu-
lated using the molar extinction coefficient of 14.9 mM
-
1 cm
-1 settled by Martin and Black [27].
GST activities
GST activities in microsomal (MF II) and cytosolic (CF)
fractions were determined as described in details by
Habig et al [28]. Briefly, 100 mM K2HPO4 buffer solution
pH 6.5, 1 mM 1-chloro-2,4-dinitrobenzene, 1 mM glu-
tathione, 5 μg( C F )o r5 0μg (MF II) of protein and 0.1%
Triton X-100 (MF II only) were added to the cuvette
(final volume of 1 mL) where the reaction took place.
The differential absorbance was recorded using a spec-
trophotometer Shimadzu UV 1601® (set at 340 nm) and
the amount of conjugate formed was calculated using the
molar extinction coefficient of 9.6 mM
-1 cm
-1 [28].
Measurement of GSH levels
After mouse death, the liver was removed as quickly as
possible, washed in iced PBS, dried and homogenized in
100 mM NaPO4 5 mM EDTA buffer solution [29]. The
hepatic homogenate was centrifuged at 10 000 × g at 4°C
for 15 min and the supernatant was frozen and kept at
-70°C until further use. After thawing, the supernatant
(10 μL) was incubated with 12.5 μL of 25% phosphoric
acid and 37 μL of 0.1 mM NaPO4 5 mM EDTA buffer
solution pH 8.0 for 10 min at 4°C. It was centrifuged
again at 13 000 × g for 10 min at 4°C, and the newly
obtained supernatant was incubated with 0.1% o-
phthaldialdehyde methanol solution and the same basic
buffer solution for additional 15 min at room tempera-
ture. GSH concentration was then measured using a
spectrofluorimeter (Shimadzu RF 5301 PC®) with wave-
length parameters set at 350 nm (excitation), 420 nm
(emission) and 3 nm (band slit width) and GSH stan-
dard curve [30,31].
Thiobarbituric acid reactive substances (TBARS) assay
TBARS were measured as described by Hermes-Lima et
al [32]. Livers were homogenized in a 0.2% phosphoric
acid solution (1:5, w/v) and in another volume of a 2.0%
phosphoric acid solution. 0.4 mL aliquots of homoge-
nized tissue received the same volume of either 10 μM
butylated hydroxytoluene (BHT) 1% thiobarbituric acid
(TBA) - samples - or 3 mM HCl - blanks (each sample
having its own blank). Both tubes received 0.2 mL of 7%
phosphoric acid and were heated in boiling water for 15
min. After cooling at room temperature, the tubes
received 1.5 mL of butanol, were vortex vigorously for
40 sec and centrifuged for 10 min. Two distinct phases
appeared, an organic phase on the top (TBA-MDA
complex) and an aqueous phase on the bottom. The
absorbance of organic phase supernatant was read at
532 nm and 600 nm while blanks were scanned between
400 and 600 nm. To calculate malondialdehyde (MDA)
concentration, absorbance at 600 nm was subtracted
from that at 532 nm and a molar absorption coefficient
of 156 mM
-1cm
-1 was used [32].
Nitric oxide (NO) levels in blood serum
NO production was evaluated by measuring total nitrite
in serum as described in details elsewhere [33]. Briefly,
nitrate was reduced to nitrite by incubating the serum
sample with a nitrate reductase and the total amount of
nitrite was then determined by the Griess method.
Results are expressed as μM concentration of NO2
-.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis (iNOS, HO-1)
Levels of mRNA in the liver and spleen were deter-
m i n e db yr e a lt i m eR T - P C Ra sf o l l o w s .R N A
was extracted using Trizol® reagent, quantified in a
Nanodrop® spectrophotometer, used (3 μg) as template
to cDNA synthesis. The cDNA synthesis reaction was
conducted in a Mastercycler Gradient thermocycler
(Eppendorff®) using Superscript II® system (Invitrogen®)
and oligo DT primers (Promega®). Relative expressions
of iNOS and HO-1 were determined using Taqman®
assays (Applied Biosystems®). Assays Mm00440485_m1
and Mm00516007_m1 were used for iNOS and
HO-1 respectively, and the assay 4352341E was used
for b-actin (endogenous control). Real time reactions
were conducted in a 7500 Fast real time thermocycler
(Applied Biosystems®). The relative quantification of
the target genes was made using the ΔΔCt method.
Gel electrophoresis (SDS-PAGE) and immunoblotting
analysis (GRP78 protein)
SDS-PAGE was performed using 8% polyacrilamide
resolving gel as described by Laemmli [34]. Microsomal
proteins were separated by applying a constant current
(30 mA) onto the gel (Hoefer miniVE system, GE
Healthcare®). After separation, microsomal proteins were
transferred into nitrocellulose membranes (Hybond ECL,
GE Healthcare®) using the Hoefer miniVE semi-dry sys-
tem (GE Healthcare®). Primary antibody was a rabbit
polyclonal IgG (SC 13968, Santa Cruz Biotechnologies®,
lot # F2206) against an epitope corresponding to amino
acids 525-653 mapping at the C-terminus of the 78 kDa
glucose-regulated protein (GRP78) of human origin. The
blots were developed using a commercially available
alkaline phosphatase kit (BIORAD® AP conjugate sub-
strate kit).
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Modulation of liver CYP activities during P. berghei
(lethal) infection
Plasmodium berghei caused a severe and deadly illness
in DBA-2 and C57BL/6 mice. In DBA-2 mice, parasitae-
mia rose steadily from post-infection day (PID) 4
onwards, reaching rates as high as 40% PE on PID20
(Figure 1A). Clinical signs such as piloerection, tachyp-
nea and hypoactivity became progressively more fre-
quent and severe as parasitaemia rate increased. From
PID8 onwards, spleens of infected mice were darker and
markedly enlarged, being almost 10-fold heavier than
non-infected mice’s spleens on PID20. Livers from
infected DBA-2 mice were also darker and somewhat
larger than those from non-infected controls on PIDs 16
and 20 (Figure 1C). The clinical course of infection in
C57BL/6 mice differed from that noted in the DBA-2
strain (Figure 2). Around PID10, when parasitaemia
rates were nearly 15-20% PE (Figure 2A), most infected
C57BL/6 mice exhibited neurological signs (ataxia, roll-
ing and other signs of motor impairment) consistent
with cerebral malaria which rapidly progressed to death.
On PIDs 6, 8 and 10 C57BL/6 mice’ss p l e e n sw e r e
enlarged (1.5 to 2-fold heavier than controls’ spleens)
and darker but no hepatomegaly was detected (Figure
2C). A remarkably high susceptibility of P.berghei-
infected C57BL/6 mice to develop cerebral malaria was
noted in other studies as well [35].
Alterations of liver monooxygenase activities during P.
berghei i n f e c t i o na r ea l s os h o w ni nF i g u r e s1( D B A - 2 )
and 2 (C57BL/6). The effects of P.berghei infection on
DBA-2 liver enzymes were not examined beyond PID20
because mortality was high after this day. As shown in
Figure 1, activities of CYP2a5 and 1a were up and
down-regulated, respectively, only at the terminal stage
o fi n f e c t i o n( E R O D :P I D 2 0 ;C O H :P I D 1 6a n d2 0 ) .T h e
activity of CYP2b, however, showed a progressive
depression - from PID8 on - as infection evolved to a
more severe stage (Figure 1B).
Since P.berghei infection in C57BL/6 mice evolved
rapidly to death, it was not possible to evaluate eventual
changes of CYP-mediated activities at higher parasitae-
mia rates. On PIDs 8 and 10, CYP1a and 2b activities
remained nearly unchanged after infection while a non-
significant increase in CYP2a5 activity was noted (Figure
2B).
Changes of CYP activities in P. chabaudi- infected mice
(non-lethal malaria)
The time course of P. chabaudi infection in DBA-2 and
C57BL/6 mice was evaluated in a preliminary experi-
ment. In both strains, parasitaemia rates gradually
increased after infection, reached a maximum rate
(approx. 40% PE) on PID5 and declined to 2-5% PE on
PID10 (Figure 3). A secondary peak of parasitaemia
(10% PE) on PID14 appeared only in DBA-2 mice. No
deaths were noted among P. chabaudi-infected mice
and, except for piloerection on PIDs 5-6 (parasitaemia
peak), infection evolved without major signs of illness.
In both strains, from the day of parasitaemia peak
(PID5) onwards spleens became markedly enlarged.
Livers of infected DBA-2 and C57BL/6 mice were also
darker and enlarged on PIDs 10-19 and 14-19, respec-
tively (Figures 4A, 4C, 5A and 5C).
In the DBA-2 strain of mice, an induction of CYP2a5
activity (COH) was found on the day of peak parasitae-
mia (PID5) only, while activities of CYP1a (EROD) and
2b (BROD) remained unaltered at all times after infec-
tion (Figure 4B). In C57BL/6 mice infected with P.cha-
baudi, however, the activity of CYP2a5 (COH) was not
altered during the whole course of the infection,
although the activities of CYP1a (EROD) and 2b
(BROD) were depressed around the day of peak parasi-
taemia, PIDs 2-6 and PID5, respectively (Figure 5B).
Nitric oxide (NO) production during the course of
P. berghei and P. chabaudi infections
A slight (<two-fold) increase in serum levels of NO was
observed on the day of P.chabaudi parasitaemia peak
(PID5) in C57BL/6 (Figure 5A), or after this day (PID6)
in DBA-2 mice (Figure 4A). During the course of P.ber-
ghei infection no increase in serum levels of NO was
observed in either mouse strain used in this study (Fig-
u r e s1 Aa n d2 A ) .R e s u l t s ,t h e r e f o r e ,i n d i c a t e dt h a t ,a s
far as DBA-2 mice infected with P.berghei are con-
cerned, depression of CYP1a and 2b activities in the
liver occurred in the absence of any discernible increase
in NO serum levels. Nonetheless, results showed that
expression of iNOS mRNA in livers and spleens was
enhanced in DBA-2 and C57BL/6 mice infected with
P. berghei (Figure 6). As shown in Figure 6A, up-regula-
tion of liver iNOS by P.berghei infection was comparable
to that observed in DBA-2 mice that had been treated
12 hours earlier with LPS (5 mg/kg body wt i.p.).
Activity of GST and UGT, and levels of GSH and TBARS in
the liver of P. berghei-infected mice
Activities of cytosolic and microsomal GSTs as well as
the activity of UGT remained nearly unaltered in the
liver of P.berghei-infected DBA-2 and C57BL/6 mice
(Table 1). Results also showed that P.berghei infection
produced a marked reduction of hepatic levels of GSH
in C57BL/6 but not in DBA-2 mice. Levels of substances
reacting with thiobarbituric acid (TBARS), however,
were increased in DBA-2, but not in C57BL/6 mice
(Table 1), a finding that seems to indicate that infection
enhanced liver lipids peroxidation and oxidative stress
in the former but not in the latter strain.
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Page 5 of 17Figure 1 Effects of P.berghei infection on CYP activities, NO production and liver weights in DBA-2 mice. Time course of changes of liver
CYP activities (CYP1a: EROD, 2b: BROD, 2a5: COH), NO serum levels, and liver and spleen weights in DBA-2 mice infected with P.berghei (ANKA).
Panel A shows NO serum levels (μM) and parasitaemia rates (%PE). Results in Panel B (enzyme activities) and C (liver and spleen weights) are
shown as % of mean values for non-infected controls (day 0 = 100) and comparisons were made by ANOVA and Dunnett’s post-hoc test. In
panels B and C statistical evaluation was made with untransformed data. Differences (P < 0.05) from non-infected control group (day 0) are
indicated by an asterisk (*) superscript. Panels B and C control values (100%) are as follows (mean ± S.E.M.): EROD = 94.7 ± 41 pmol resorufin/mg
protein/min; BROD = 74.6 ± 21 pmol resorufin/mg protein/min; COH = 193.9 ± 27 pmol umbelliferone/mg protein/min; liver wt = 0.99 ± 0.02 g;
spleen wt = 0.08 ± 0.04 g. Control NO = 35.4 ± 2.8 μM (Panel A). Numbers of mice used (N) are as follows: PID0 = 15; PID4 = 10; PID8 = 10;
PID12 = 10; PID16 = 11; PID20 = 14. Of 9 infected mice that were not killed (not included), 2 died on PID22, and 7 on PID24. No infected DBA-2
exhibited neurological signs of cerebral malaria.
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Page 6 of 17Figure 2 Effects of P.berghei infection on CYP activities, NO production and liver weights in C57BL/6 mice. Time course of changes of
liver CYP activities (CYP1a: EROD, 2b: BROD, 2a5: COH), NO serum levels, and liver and spleen weights in C57BL/6 mice infected with P.berghei
(ANKA). Panel A shows NO serum levels (μM) and parasitaemia rates (%PE). Results in Panel B (enzyme activities) and C (liver and spleen weights)
are shown as % of mean values for non-infected controls (day 0 = 100) and comparisons were made by ANOVA and Dunnett’s post-hoc test. In
panels B and C statistical evaluation was made with untransformed data. Differences (P < 0.05) from non-infected control group (day 0) are
indicated by an asterisk (*) superscript. Panels B and C control values (100%) are as follows (mean ± S.E.M.): EROD = 103.1 ± 33.5 pmol resorufin/
mg protein/min; BROD = 87.3 ± 12.3 pmol resorufin/mg protein/min; COH = 9.81 ± 2.5 pmol umbelliferone/mg protein/min; liver wt = 0.99 ±
0.05 g; spleen wt = 0.09 ± 0.01 g. Control NO = 37.95 ± 2.4 μM (Panel A). Numbers of mice used (N) are as follows: PID0 = 5; PID2 = 7; PID4 =
7; PID6 = 7; PID8 = 7; PID10 = 3. Numbers of infected mice which died (not included): PIDs8/9 = 5, PIDs9/10 = 13. From day 8 onwards, all
infected mice that were killed or died presented neurological signs of CM.
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haem oxygenase (HO-1) in the liver of DBA-2 mice
Disruption of red blood cells during parasite schizogony
produces cell-free haemoglobin that is oxidized releasing
its haem prosthetic group (free haem), a pro-oxidant
and cytotoxic substance. HO-1 plays a major role in the
catabolism of free haem and thus it protects host liver
cells from free haem deleterious effects during severe
malaria infections [36,37]. As shown in Figure 7, levels
of HO-1 mRNA in the liver of P.berghei-infected DBA-2
mice (parasitaemia >30% PE) were nearly 3-fold levels
found in non-infected controls. The concurrent up-reg-
ulation of CYP2a5 (Figure 1B) and HO-1 (Figure 7) in
the liver of P.berghei-infected DBA-2 mice is consistent
with the idea advanced by Abu-Bakar et al [10] that
CYP2a5 takes part in the catabolism of bilirubin, and
that coordinated induction of both oxidases results in a
balance between overproduction and degradation of
bilirubin in response to free haem excess.
Effect of P. berghei infection on the level of glucose-
regulated protein 78 (GRP78) in the mouse liver
The overexpression of glucose-regulated protein 78
(GRP78), an endoplasmic reticulum-resident chaperone,
has been used as a biomarker of endoplasmic reticulum
(ER) stress [9,38]. As shown in Figure 8, densitometric
analysis of Western blots revealed that pyrazole
Figure 3 Time course of non-lethal malaria (P.chabaudi chabaudi) infection in female DBA-2 and C57BL/6 mice. Parasitaemia rates (%PE)
were determined following inoculation of P. c. chabaudi (2 × 10
7 PE i.p.) on infection day 0 (PID0). Bar heights are means ± S.E.M. of % of
parasitized erythrocytes (%PE). Number of mice used (N): DBA-2 = 5; C57BL/6 = 5.
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Page 8 of 17Figure 4 Effects of P. c. chabaudi infection on CYP activities, NO production and liver weights in DBA-2 mice. Time course of changes of
liver CYP activities (CYP1a: EROD, 2b: BROD, 2a5: COH), NO serum levels, and liver and spleen weights in DBA-2 mice infected with P.chabaudi
chabaudi. Panel A shows NO serum levels (μM) and parasitaemia rates (%PE). Results in panels B (enzyme activities) and C (liver and spleen
weights) are shown as % of mean values for non-infected controls (day 0 = 100) and comparisons were made by ANOVA and Dunnett’s post-
hoc test. In panels B and C statistical evaluation was made with untransformed data. Differences (P < 0.05) from non-infected control group (day
0) are indicated by an asterisk (*) superscript. Panels B and C control values (100%) are as follows (mean ± S.E.M.): EROD = 130.8 ± 6.7 pmol
resorufin/mg protein/min; BROD = 73.7 ± 3.1 pmol resorufin/mg protein/min; COH = 149.4 ± 8.0 pmol umbelliferone/mg protein/min; liver
wt = 1.08 ± 0.01 g; spleen wt = 0.11 ± 0.005 g. Control NO = 42.25 ± 1.7 μM (Panel A). Numbers of mice used (N) are as follows: PID0 = 8;
PID2 = 8; PID5 = 8; PID6 = 8; PID10 = 8, PID14 = 8; PID19 = 8.
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Page 9 of 17Figure 5 Effects of P. c. chabaudi infection on CYP activities, NO production and liver weights in C57BL/6 mice. Time course of changes
of liver CYP activities (CYP1a: EROD, 2b: BROD, 2a5: COH), NO serum levels, and liver and spleen weights in C57BL/6 mice infected with P.
chabaudi chabaudi. Panel A shows NO serum levels (μM) and parasitaemia rates (%PE). Results in Panel B (enzyme activities) and C (liver and
spleen weights) are shown as % of mean values for non-infected controls (day 0 = 100) and comparisons were made by ANOVA and Dunnett’s
post-hoc test. In panels B and C statistical evaluation was made with untransformed data. Differences (P < 0.05) from non-infected control group
(day 0) are indicated by an asterisk (*) superscript. Panels B and C control values (100%) are as follows (mean ± S.E.M.): EROD = 182.4 ± 5.8 pmol
resorufin/mg protein/min; BROD = 121.2 ± 6.0 pmol resorufin/mg protein/min; COH = 16.5 ± 1.2 pmol umbelliferone/mg protein/min; liver
wt = 0.84 ± 0.02 g; spleen wt = 0.07 ± 0.003 g. Control NO = 51.12 ± 2.36 μM (Panel A). Numbers of mice used (N) are as follows: PID0 = 10;
PID2 = 14; PID5 = 10; PID6 = 6, PID10 = 6; PID14 = 6; PID19 = 8.
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Page 10 of 17(100 mg/kg i.p. 24 h earlier), a hepatotoxic and ER-
stress inducing agent, induced GRP78 in the liver of
DBA-2 mice. P.berghei infection, however, did not ele-
vate the expression of GRP78 protein over the levels
found in non-infected controls (Figure 8), thereby indi-
cating that blood stage malaria (parasitaemia >30%PE)
did not elicit ER stress in the liver of DBA-2 mice.
Discussion
Data provided by this study confirmed that P.berghei infec-
tion induces CYP2a5 (COH) and depresses CYP1a
(EROD) and 2b (BROD) activities in the liver of DBA-2
mice [7]. Furthermore, it was also shown that non-lethal
(P.c.chabaudi) infection up- (CYP2a5) and down- (CYP1a
and 2b) modulates CYP activities in the liver of DBA-2
and C57BL/6 mice on the day, and/or shortly before or
after the day on which parasitaemia peak was recorded. It
is of note that CYP activities remained almost unaltered in
C57BL/6 mice infected with P.berghei,m o s to fw h i c h
developed severe neurological symptoms compatible with
cerebral malaria. Compared to P.berghei-infected DBA-2,
however, C57BL/6 mice presented lower parasitaemia
Figure 6 Effects of P. berghei infection on iNOS mRNA expression in mice liver and spleen. Expression of iNOS mRNA in the liver and
spleen of DBA-2 (A and B, N = 3) and C57BL/6 (C and D, N = 4) mice infected with P. berghei (ANKA), when parasitaemia rates rose to levels
>30%PE (DBA-2) on PID20 or >20%PE (C57BL/6) on PID10 and respective non-infected controls (N = 3). For comparative purposes, levels of iNOS
mRNA were also determined in the liver (A, N = 6) and spleen (B, N = 5) of non-infected DBA-2 mice treated with E. coli LPS (5 mg/kg i.p. 12
hours earlier). Column height represents mean ± S.E.M. for relative levels of mRNA. Differences (Mann-Whitney U test, P < 0.05) between infected
(malaria) and non-infected control (Ctrl) are indicated by an asterisk (*). Quantification of mRNA was by real time RT-PCR.
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Page 11 of 17rates before dying with cerebral malaria symptoms. Modu-
lation of CYP activities by malaria, therefore, is not neces-
sarily associated with a terminal stage of an invariably
lethal infection, because, on one side, it was not observed
in mice (C57BL/6) developing a severe and deadly cerebral
malaria, and, on the other side, it occurred near the parasi-
taemia peak in animals with non-lethal infections. Taken
together, findings presented here suggested that high para-
sitaemia rate was a major clinical feature associated
with infection-produced alterations of liver CYP activities
regardless of whether infection further progressed toward
the death (P.berghei)o rc u r e( P.chabaudi)o fm a l a r i o u s
mice. Additionally, necropsy data showed that livers of
P.chabaudi-infected mice, due to a continuous accumula-
tion of malaria pigment (haemozoin), became even darker
and more enlarged after the day of parasitaemia peak,
when CYP activities had returned to the levels recorded in
non-infected controls. The foregoing observation sug-
gested that up- (CYP2a5) and down- (CYP1a and 2b) reg-
ulations of liver CYP activities during malaria infections
do not seem to be associated with accumulation of haemo-
zoin in the hepatic tissue.
Table 1 Phase-II enzyme activity, glutathione and TBARS in the liver of P.berghei-infected mice
Parameters GST UGT GSH TBARS
Sub-cellular fraction m c m c -
DBA-2 Infected
(N)
80.4 ± 4.5
(8)
700 ± 100
(8)
8.4 ± 3.2
(8)
86.0 ± 8.0
(7)
13.5 ± 3.9
(5)
Control
(N)
91.0 ± 5.4
(8)
800 ± 100
(8)
9.0 ± 3.0
(8)
76.9 ± 9.0
(7)
39.0 ± 5.5*
(5)
C57BL/6 Infected
(N)
85.6 ± 6.1
(8)
1 400 ± 100
(6)
7.4 ± 3.7
(9)
35.0 ± 9.8
(6)
19.5 ± 2.7
(5)
Control
(N)
95.9 ± 2.7
(8)
1 500 ± 100
(8)
5.5 ± 3.0
(9)
16.9 ± 8.6*
(8)
23.6 ± 12.3
(5)
Data are mean ± S.E.M. m: microsomal fraction; c: cytosolic fraction; (N): number of animals. Values different from those for non-infected controls (Student’s
t test, P < 0.05) are indicated by an asterisk (*). Enzyme activities are expressed as nmol/mg ptn/min (mGST and UGT) and μmol/mg ptn/min (cGST). GSH as
nmol/mg ptn; TBARS as nmol MDA/g wet tissue.
Figure 7 Effects of P. berghei infection on haemoxygenase-1 mRNA expression in the liver of DBA-2 mice. Expression of HO-1 mRNA in
the liver of DBA-2 mice infected with P.berghei (ANKA), when parasitaemia rates rose to levels >30%PE on PID20, and respective non-infected
controls. Column height represents mean ± S.E.M. for relative levels of mRNA of 6 mice. Differences (Mann-Whitney U test, P < 0.05) between
infected (malaria) and non-infected controls (Ctrl) are indicated by an asterisk (*). Quantification of mRNA was by real time RT-PCR.
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Page 12 of 17CYP2a5 is induced by phenobarbital, pyrazole, virus
and bacterial hepatitis as well as by liver fluke (Fas-
ciola hepatica and Opisthorchis viverrini)i n f e c t i o n s
[ 3 9 - 4 1 ] .R e c e n t l y ,i tw a sd e s c r i b e dt h a tC Y P 2 a 5i s
induced in DBA-2 and C57BL/6 mice infected with
P. berghei ANKA[7]. All aforementioned infections and
the prototypical CYP2a5-inducer pyrazole - but not
phenobarbital - produced extensive liver injury and a
marked rise in serum levels of ALT and AST as well
[9]. The expression of CYP2a5 in a glucose-6-phos-
phate dehydrogenase (G6PD)-deficient mouse model of
oxidative stress was studied by Nichols and Kirby [42].
The G6PD-deficient mouse exhibits increased suscept-
ibility to oxidative stress and the authors found that
treatment of wild type and G6PD-deficient mice with
pyrazole for 72 hours led to a greater degree of
induction of CYP2a5 in the deficient animals. TBARS
and other markers of oxidative stress, however, were
not altered by pyrazole either in wild or in G6PD-defi-
cient mice. On the other side, oxidative stress markers
were enhanced, whereas CYP2a5 was not induced by
treatment of wild type or G6PD-deficient mice with
menadione, a pro-oxidant agent. Nichols and Kirby
[42] also noted that pyrazole produced a greater
increase in GRP78 protein in G6PD-deficient mice
than in wild type mice, and that menadione did
not alter GRP78 levels either in wild type or in G6PD-
deficient animals. Based on these findings, the authors
suggested that generalized cellular oxidative stress does
n o tp l a yak e yr o l ei nt h eu p - r e g u l a t i o no fC Y P 2 a 5a n d
that other factors related to G6PD-deficiency such as
ER stress may be involved.
Figure 8 Effect of P. berghei infection on GRP78 protein expression in the liver of DBA-2 mice. Immunoblot analysis - with a polyclonal
antibody against GRP78 - of liver microsomes from female DBA-2 mice infected with P. berghei (Malaria) on PID20, non-infected controls
(Control) and non-infected mice treated with pyrazole (Pyrazole), 100 mg/kg body wt i.p. Densitometric analysis is shown in the lower panel.
Height of histogram bars are means ± S.D. of arbitrary optical density units. Difference from non-infected control group is indicated by an
asterisk (*, P < 0.05, Mann-Whitney U test). 50 μg of microsomal protein from a different mouse was applied on each lane. The immonoblot
shown in the figure is representative of others with similar results.
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of the putative oxidative stress marker TBARS
were increased, while expression of GRP78 remained
unchanged in the liver of P.berghei-infected DBA-2
mice. The effects of malaria on TBARS and GRP78
expression were similar to the effects of menadione, a
pro-oxidant agent non-inducer of CYP2a5, and con-
trasted with the effects of pyrazole, a prototypical indu-
cer of CYP2a5. Therefore, it seems difficult reconciling
all aforementioned studies findings through a common
hypothesis on the role of oxidative stress and ER stress
on CYP2a5 induction by chemicals and infections.
Nonetheless, it should be borne in mind that lack of
GRP78 induction does not necessarily imply that malaria
elicited no ER stress. Although being considered a mar-
ker of ER stress, GRP78 over-expression is in fact a
homeostatic response that protects the cell against
damage caused by ER dysfunction or stress. If GRP78
were not up-regulated, ER stress would result in more
marked ER accumulation of unfolded proteins and more
severe hepatocellular injury. This interpretation is con-
sistent with elevated serum ALT and AST levels noted
in P.berghei-infected DBA-2 mice [7], an indication that
enhanced oxidative stress during malaria may have
caused liver cell injury.
HO-1 is an inducible and rate-limiting enzyme of
haem catabolic pathway. It catalyzes the opening of por-
phyrin ring to form biliverdin that is subsequently con-
verted to bilirubin by biliverdin reductase. Circulating
free haem is a potent oxidant and cytotoxic agent and
thus up-regulation of HO-1 expression by oxidative
stress, heavy metals and a variety of other inducers is
regarded as a protective response. Although being a pro-
tective antioxidant compound, bilirubin is very hydro-
phobic and may also cause toxicity when it is
accumulated in tissues due to impaired conjugation and
excretion (e.g. neurotoxicity in neonatal jaundice and
cholestatic diseases). The main route of bilirubin elimi-
nation involves glucuronidation mediated by UGT1A1
and excretion of conjugated metabolites into the bile.
Nonetheless, it has been suggested that oxidative meta-
bolism of bilirubin would be an important alternative
route of elimination when glucuronidation is impaired
[10]. Based on the observation that CYP2a5 is induced
by substances known to affect haem balance, including
metals and porphyrinogenic agents [43], Abu Bakar et al
[10] suggested that CYP2a5 plays a role in the oxidative
metabolism of bilirubin. Moreover, the authors pointed
o u tt h a tt h ef o r e g o i n gC Y P 2 a 5i n d u c e r sa l s ou p - r e g u -
lated HO-1, and that CYP2a5 over-expression is often
associated with a decrease of total CYP content, which
in turn has been shown to be associated with HO-1
induction as well. A hypothesis was advanced that a
coordinated regulation of CYP2a5 and HO-1
expressions contributes to achieving a balance between
bilirubin production and elimination. The concurrent
induction of CYP2a5 and HO-1 in the liver of P. ber-
ghei-infected DBA-2 mice is consistent with this view
[10].
Contrasting with the up- and down-modulation of
CYPs, activities of liver conjugation enzymes (UGT and
microsomal and cytosolic GST) remained unchanged in
P.berghei-infected mice. Carvalho et al [6] also found
that UGT activity was unaltered in liver microsomes of
Swiss Webster mice infected with P. berghei.M u r d o c h
et al [44], however, evaluated phenol conjugation in per-
fused rat livers and noted that P.berghei infection
decreased phenol glucuronide formation. Along the
same line, Ismail et al [ 4 5 ]d e s c r i b e dt h a tm a l a r i a
impaired glucuronidation of paracetamol in rats in vivo.
In both cases, ex vivo and in vivo reductions in phenol
and paracetamol glucuronidations may have been due to
a lower availability of the co-substrate uridine dipho-
sphoglucuronic acid (UDPGA) in the liver of infected
rats. As pointed out by Murdoch et al [44], UDPGA
availability depends on hepatic glycogen stores, which
were partially depleted in malarious rats. Therefore,
even if expression and catalytic activity of UGT remains
unaltered, a lower availability of the co-substrate
UDPGA in the liver of malarious individuals may even-
tually reduce the rate of glucuronidation reactions.
There are few data on the effects of rodent malaria on
the expression and activity of GSTs in the host liver.
Results from this study with P.berghei ANKA infections
are at variance with those reported by Ahmad and Sri-
vastava [46] for mice infected with Plasmodium yoelii
nigeriensis. The authors found a decline of microsomal
and cytosolic GST activities in the liver and spleen of
infected mice that were to some extent reversed by
treatment with mefloquine and menadione. The differ-
ences between results from this study and those
reported by Ahmad and Srivastava [46] are possibly
explained by differences regarding parasite species, mur-
ine strains and severities of malaria infection.
During malaria infection both hosts and parasites are
under oxidative stress and reactive oxygen species (ROS,
e.g., superoxide anions and hydroxyl radicals) are pro-
duced by host’s activated neutrophils and by the degra-
dation of haemoglobin by parasites as well. Although
killing the parasite, enhanced ROS production also con-
tributes to pathological changes in the host including
red blood cell sequestration, cerebral pathology, anemia,
and respiratory distress. Data from this study showed
that levels of TBARS - a marker for lipid peroxidation
and oxidative stress - were enhanced in the liver of
DBA-2 mice infected with P.berghei, thereby supporting
the view that hepatic tissue is under oxidative stress
during severe malaria infection. No alteration of TBARS
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On the day of sacrifice, however, infected C57BL/6 mice
exhibited lower parasitaemia rates and less darkened
and enlarged livers than infected DBA-2 mice. Levels of
GSH in the liver, on the other side, were reduced by
i n f e c t i o ni nC 5 7 B L / 6b u tn o ti nD B A - 2 .I ti so fn o t e
that background levels (i.e., non-infected control levels)
of GSH in the DBA-2 strain were higher than in the
C57BL/6 strain. It is not clear why hepatic GSH levels
were depleted by malaria in C57BL/6 mice but not in
DBA-2 mice. A number of factors can affect the avail-
ability of GSH (a powerful antioxidant) in the liver and
owing to this fact a decline of the ratio between reduced
(GSH) and oxidized (GSSG) glutathione is a more reli-
able indicator of imbalance between pro-oxidant and
antioxidant mechanisms (oxidative stress) than a
decrease of GSH levels.
Nonetheless, data from this study strongly suggest
that, owing to their lower levels of GSH, infected
C57BL/6 mice are more vulnerable to hepatic injury
(including DNA damage) caused by electrophiles than
non-infected mice.
It is well known that NO production in response to
secretion of pro-inflammatory cytokines during infection
and inflammation is mediated by an up-regulation of
iNOS [47]. In human malaria, NO has been suggested
to have a dual role. In P. falciparum malaria, despite
mediating the intra-hepatic killing of the parasite, NO is
thought to contribute to the pathogenesis of the disease
[47]. In rodent malaria, however, the role of NO is still
unclear. Despite the general idea that it depends on the
parasite-host relationship, iNOS mRNA induction in
rodent malaria may vary according to the stage of infec-
tion, the degree of parasitaemia, the species and strain
of Plasmodium and the target organ or tissue examined
[48]. In this study, no enhancement of serum NO was
found in P.berghei-infected mice while slight increases
of serum levels of NO were observed near the day of
parasitaemia peak in P.chabaudi-infected animals. None-
theless, levels of iNOS mRNA in the liver of P.berghei-
infected mice were higher than levels in non-infected
controls, thereby indicating that iNOS expression was
up-regulated by lethal malaria. A possible explanation
for unchanged serum levels of NO, in the presence of
over-expression of iNOS in hepatic and splenic tissues,
is an increase in NO scavenging by free haemoglobin in
the blood of infected mice. Nitric oxide binds avidly to
haem iron, and haemoglobin (Hb) is released into the
circulation when red blood cells (RBC) are disrupted
during parasite schizogony. Along this line, Sobolewski
et al [49] found that plasma levels of free Hb were
rather high in P.berghei-infected mice (e.g. on PID6),
and additionally demonstrated in vitro that cell free Hb
is at least 1 000 times more efficient in scavenging NO
than the intracellular Hb. It should be pointed out that
intravenous infusions of cell free haemoglobin and
chronic haemolysis due to sickle-cell disease limit NO
bioavailability as well [50]. The induction of iNOS
mRNA expression in P.berghei-infected mice strongly
suggested that malaria infection elicited NO production
in the hepatic tissue. The idea that NO is a mediator of
the down-modulation of CYP expression by inflamma-
tory stimuli is plausible because NO binds haem pro-
teins and inhibits catalytic activities of CYPs in in vitro
test systems [16,17]. Nonetheless, Khatsenko and cowor-
kers’ hypothesis has not been supported by data pro-
vided by other authors. Sewer et al [18], for instance,
reported that LPS depressed the expression of CYP2c29,
2e1 and 3a11 in iNOS knockout mice. More recently,
however, Morgan and coworkers [2,51] showed that NO
over-production caused a selective depression of CYP2b
rather than an unspecific down-regulation of CYPs.
Furthermore, Lee et al [51] showed that CYP2b under-
went a post-transcriptional NO-dependent ubiquitina-
tion and proteosomal degradation and suggested that
these events are triggered by a modification of aminoa-
cid residues of CYP2b proteins by reactive nitrogen spe-
cies. If this view holds true, it seems fair to think that
NO overproduction arising from iNOS up-regulation in
the hepatic tissue is the mechanism, or one of the
mechanisms, by which malaria depressed CYP2b activity
in the mouse liver.
The mechanism by which malaria down-modulates
the expression and activity of other CYP isoforms is still
unclear. Gu et al [52] suggested that NFBa c t i v a t i o n
c o u l dp l a yar o l ei nt h ed o w n - m o d u l a t i o no fC Y P sb y
inflammatory and infectious diseases and malaria was
reported to enhance TLR-mediated pro-inflammatory
responses [53]. Therefore, the idea that NFB activation
mediates the down-modulation of liver CYPs by blood
stage malaria seems plausible.
Finally, it should be borne in mind that there are dif-
ferences in the pathology produced by P. berghei and
P.chabaudi in murine hosts and that caused by P. falci-
parum and Plasmodium vivax in humans. Results from
this study showed that up- and down-regulation of CYP
activities during P.berghei and P.chabaudi infections
occurred when parasitaemia rates were high. Compared
to the hyperparasitaemia noted in murine infections,
parasitaemia rates in human P.falciparum infection are
low due to the adherence of trophozoite/schizont-
infected erythrocytes to the endothelium of capillaries
and venules. Nonetheless, it was reported that, in
patients with P.falciparum malaria, clearance rates of
quinine [54] and caffeine [55] were slower thereby sug-
gesting that drug metabolism is depressed during
human malaria as well. There are only a few studies on
the influence of malaria on drug metabolism in humans
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kinetics in P.falciparum and also in P.vivax malaria. At
any rate, data presented here demonstrated that liver
CYP activities are modulated during murine lethal and
non-lethal infections and it seems fair to think that this
modulation of enzymes involved in drug metabolism
also occurs in human falciparum malaria.
Conclusion
In conclusion, results from this study showed that
down-regulation of CYP1a and 2b, as well as up-regula-
tion of CYP2a5 occur in both lethal and non-lethal mur-
ine malaria. It was also demonstrated that alterations of
CYP activities in murine malaria occurred only when
parasitaemia rates were high, and apparently were not
associated with liver enlargement and haemozoin accu-
mulation. Since iNOS was induced in the liver of P.ber-
ghei-infected mice, a contribution of NO for depression
of CYP2b activity cannot be ruled out. No induction of
GRP78 was found in P.berghei-infected mice, a finding
that suggests that CYP2a5 up-modulation may occur in
the absence of ER stress. Finally, results from this study
are consistent with the view that HO-1 and CYP2a5 are
concurrently up-regulated in the mouse liver.
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